AHF Challenges Merck's ‘Criminal AIDS Drug Pricing’ for Isentress

As part of its ongoing campaign to lower drug prices and increase access, AIDS Healthcare Foundation (AHF) unveiled its latest advocacy campaign challenging Merck and Co. Pharmaceuticals over the steep price of its key HIV/AIDS drug, Isentress (raltegravir).
Fox Business